When breast carcinomas were categorized into basal-like, HER2-enriched, and ER+ (luminal) molecular subtypes, both HER2-enriched and ER+ subgroups had significantly augmented FASN protein expression compared to basal-like breast carcinomas (Figure 7). The gene discussed is ESR1; the disease is breast carcinoma.